Paxilline

貨號 Cat. No.
P-450
規格 Size
0.45 mg 5x0.45mg

Description

 



Paxilline



A Mycotoxin Blocker of KCa1.1 (BK) Channels










Product#: P-450













Sizes:
0.45 mg
5 x 0.45 mg














M.W.: 435.6










Purity: >98%












Bioassay:

Inhibition of KCa1.1 channels by mycotoxins including Paxilline.












Left:  The effect of 100nM Paxilline (a) Penitrem A (b) and Verruculogen (c) on heterologously expressed BK currents.  Time course of current amplitude changes upon sequential applications of the three toxins.

Right:  Example of current responses to 100ms depolarization before (red) and during (black)perfusion of 500nM Paxilline.














References:


























1.

Selala, M.I. et al. (1991) J. Nat. Prod. 54, 207.

2.

Knaus, H. G. et al. (1994) Biochemistry 33, 5819.

3.

http://www.alomone.com/System/UpLoadFiles/DGallery/Docs/02_47.pdf

4.

Hu, H.  et al. (2001) J. Neurosci.21, 9585.

5.

Faber, E. S. L. and Sah, P. (2002) J. Neurosci.22, 1618.


Paxilline is a selective blocker of KCa1.1 (high-conductance Ca2+-activated K+, BK) channels. It belongs to a set of tremorgenic indole alkaloids which are lipid soluble and also include Pentrium A (#P-650) and Verruculogen (#V-500).2 Paxilline enhanced the electrically induced twitch contractions in guinea pig ileum, without influencing the contractions provoked by exogenous acetylcholine.1 Paxilline was shown to inhibit the peptidyle toxin resistant combination a+b4 channels (for more background see 3) expressed in CHO cells. 4 It was shown to be as potent as Iberiotoxin (#RTI-400) in action potential broadening in hippocampus and amygdala. 4,5 

 

詢價 / 洽詢此產品

回到產品列表

▲ LINE
諮詢